During the last session, Elevation Oncology Inc (NASDAQ:ELEV)’s traded shares were 1.8 million, with the beta value of the company hitting 1.33. At the end
In the last trading session, 1.7 million shares of the Elevation Oncology Inc (NASDAQ:ELEV) were traded, and its beta was 1.31. Most recently the company’s
In the last trading session, 2.27 million shares of the Elevation Oncology Inc (NASDAQ:ELEV) were traded, and its beta was 1.29. Most recently the company’s
Elevation Oncology Inc (NASDAQ:ELEV)’s traded shares stood at 2.86 million during the last session, with the company’s beta value hitting 1.30. At the close of
In the last trading session, 40.5 million Elevation Oncology Inc (NASDAQ:ELEV) shares changed hands as the company’s beta touched 1.27. With the company’s per share
In the latest trading session, 22.74 million Elevation Oncology Inc (NASDAQ:ELEV) shares changed hands as the company’s beta touched 1.27. With the company’s most recent
In recent trading session, Elevation Oncology Inc (NASDAQ:ELEV) saw 0.59 million shares changing hands at last check today with its beta currently measuring 1.28. Company’s
Elevation Oncology Inc (NASDAQ:ELEV) has a beta value of 1.29 and has seen 1.96 million shares traded in the recent trading session. The company, currently
During the last session, Elevation Oncology Inc (NASDAQ:ELEV)’s traded shares were 1.36 million, with the beta value of the company hitting 1.29. At the end
During the recent session, Elevation Oncology Inc (NASDAQ:ELEV)’s traded shares were 0.48 million, with the beta value of the company hitting 1.29. At the last
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
